Topping our weekly news roundup: 2018 has been called the "year of CRISPR in humans," but a new paper may tamp down some of the excitement. The study, which has not yet been peer reviewed, suggests some patients’ immune systems may be primed to attack proteins used in gene editing, rendering it ineffective.
↧